Day: 31 May 2022

Kongsberg Beam Technology raises NOK ~ 10 million for the product development of MaMa-K™ to reduce side effects in radiation therapy

PRESS RELEASE Kongsberg Beam Technology’s shareholders approved the pre-subscribed shares of NOK 10 million at the Annual General Meeting, on May 24th. Proceeds from this New Share Issue will be used for the development activities associated with MaMa-K™ and strengthen the patent portfolio. Furthermore, funds from the Research Council of Norway will be used for […]

About Kongsberg Beam Technology
Kongsberg Beam Technology strives to become a premier partner for leading companies within the radiation therapy industry. Based on its AI-supported software solution, MaMa-K can substantially enhance the performance and safety of established treatment equipment and dose-planning systems. MaMa-K makes it possible to monitor and predict anatomical and functional changes of a tumour and surrounding tissue, e.g. organs at risk, between treatment sessions. The MaMa-K software will further allow real-time optimisation of delivered radiation. With these unique properties, MaMa-K has the potential to significantly improve treatment outcomes and limit severe short- and long-term side effects.

Follow Us

© 2024 Kongsberg Beam Technology | All rights reserved